Jump to section
To transform the lives of those living with disease by improving access to research and healthcare.
71% employee growth in 12 months
uMed's founder, Dr Matt Wilson, witnessed firsthand the pressure of working on the frontline in the health system and how the lack of time and resource often led to research being de-prioritised. It's this lack of participation from healthcare providers that is a huge barrier for researchers trying to meet their patient enrolment timelines.
This is the problem Dr. Wilson set out to solve. uMed's platform is embedded across a network of healthcare providers, enabling it to automate the process of building prospective, protocolised patient registries. As a result, healthcare professionals can run patient research efficiently and at scale, as well as addressing other challenges associated with trial recruitment like high screen failure and dropout rate, speed of recruitment and achieving patient diversity.
uMed has seen great success in the space, now linking EHR records of over 10 million patients and working with an expanding network of healthcare providers from across the UK, USA and Australia. As one of a growing number of companies innovating in the healthcare space, uMed has successfully attracted fundraising which will be invested in developing its tools to run patient research more efficiently and ensuring regulatory compliance.
Steph
Company Specialist at Welcome to the Jungle
Jul 2023
$12.5m
EARLY VC
Dec 2020
$4.7m
SEED
Dr. Matt Wilson
(CEO)Previously worked at the NHS for 8 years, first as an Emergency Medicine Doctor, then Anaesthetic Specialty Trainee, and now continues to act as a Clinical Entrepreneur Fellow. Has also served as Chief Medical Officer at Ampersand & Ampersand.